Proveris SCIENTIFIC
WHITE PAPERS
Learn more about how Proveris products and services are eliminating testing variables and helping to accelerate OINDP development.
Respiratory Drug Development
Farina, D., MS Eng, Article Reprint from International Pharmaceutical Industry Journal, Spring 2021 Issue. Proveris Scientific Corporation, 2021 April
Perspective from Spray and Aerosol Characterization Expert
Complete solution for pMDI products: From development to quality control testing
Chauhan H., Proveris Scientific White Paper. Proveris Scientific Corporation, 2018 November.
Proveris Scientific outlines the major challenges encountered in testing pressurized metered dose inhalers, and how Proveris’s portfolio of instruments can be an invaluable addition to the testing workflow.
Addressing the challenges in nasal device testing: Evaluation of pump performance
Chauhan H., Proveris Scientific White Paper. Proveris Scientific Corporation, 2018 November.
Proveris Scientific addresses the challenges faced by the OINDP industry, with a particular emphasis on nasal spray devices. Solutions are offered in the form of the fully automated Indizo® system and Vereo® actuators. These instruments expedite
the analysis by effectively streamlining the workflow and eliminating manual processes. They can be used to conduct a variety of the required regulatory tests in a reproducible manner while simulating human use of the product.
What is Quality by Design and why should you care?
Newcomb A., Liu-Cordero S., Proveris Scientific White Paper. Proveris Scientific Corporation, 2017 March.
Quality by Design (QbD) is a scientific approach that formalizes product design, automates manual testing, and streamlines troubleshooting. A QbD approach is an indispensable tool for successfully developing inhaled and nasal drug products as well as critical to creating effective manufacturing processes for released products.
Reducing variability in test results for OINDPS with automated actuation
Chauhan H., Liao L., Proveris Scientific White Paper. Proveris Scientific Corporation, 2018 November.
Proveris Scientific discusses the importance of automated actuation for testing inhalation and spray devices to avoid variability introduced by manual methods, and how Proveris’s portfolio of instruments and services can ensure the accuracy and reproducibility of results.
Spray Pattern: A rapid and sensitive early development tool for respiratory drug products
Liao L., Chauhan H., Newcomb A., L’Ecuyer T., Liu-Cordero S., Leveille C., Article Reprint from Inhalation Magazine. Proveris Scientific Corporation, 2017 October.
Utilizing spray performance measurements to accelerate OINDP development.
Spray pattern as a screening tool during early development of nasal sprays
Heli Chauhan, MS, and Linda (Lingzhi) Liao, MS, Proveris Scientific Technical Article. Proveris Scientific Corporation, 2019 June. Reprint from Inhalation Magazine, 2019 June.
Using spray pattern to select an optimum device/formulation combination.
Proveris by Design™: A roadmap for in vitro characterization of combination products
Liao L., MS, Article Reprint from International Pharmaceutical Industry, Vol 12, Issue 2, 2020 April. Proveris Scientific Corporation, 2020 April.
Part 1: Stepwise guide to development of nasal sprays and pMDIs – a Proveris by Design™ approach
Part 2: Using a novel human realistic approach for in vitro Characterization to Better Predict in vivo Performance of Inhaled Aerosols
COVID-19 Partnering Supplement
Proveris Laboratories: Your trusted partner in OINDP Development
In vitro technologies and tools accelerate products to market
Flaherty I., BS, Article Reprint from International Pharmaceutical Industry, COVID-19 Supplement, 2021 January. Proveris Scientific Corporation, 2021 January.
Make informed decisions with study results & consultations with our application scientists.